448 related articles for article (PubMed ID: 27717779)
1. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Cirillo DM; Palmieri F; Ippolito G; Goletti D
J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
[TBL] [Abstract][Full Text] [Related]
2. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
Tsuyuzaki M; Igari H; Okada N; Suzuki K
J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Palmieri F; Cirillo DM; Ippolito G; Goletti D
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
[TBL] [Abstract][Full Text] [Related]
4. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes.
Allen NP; Swarbrick G; Cansler M; Null M; Salim H; Miyamasu M; Howard J; Boyle J; Lewinsohn D; Lewinsohn D
Tuberculosis (Edinb); 2018 Dec; 113():239-241. PubMed ID: 30514508
[TBL] [Abstract][Full Text] [Related]
5. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
[TBL] [Abstract][Full Text] [Related]
7. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment.
Chiacchio T; Petruccioli E; Pepponi I; Vanini V; Gualano G; Cirillo D; Palmieri F; Ippolito G; Goletti D
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S141-S142. PubMed ID: 28043513
[TBL] [Abstract][Full Text] [Related]
8. A multicentre verification study of the QuantiFERON
Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
[TBL] [Abstract][Full Text] [Related]
9. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
Pérez-Recio S; Pallarès N; Grijota-Camino MD; Sánchez-Montalvá A; Barcia L; Campos-Gutiérrez S; Pomar V; Rabuñal-Rey R; Balcells ME; Gazel D; Montiel N; Vicente D; Goić-Barišić I; Schön T; Paues J; Mareković I; Cacho-Calvo J; Barac A; Goletti D; García-Gasalla M; Barcala JM; Tórtola MT; Anibarro L; Suárez-Toste I; Moga E; Gude-Gonzalez MJ; Naves R; Karslıgil T; Martin-Peñaranda T; Stevanovic G; Trigo M; Rubio V; Karaoğlan İ; Bayram N; Alcaide F; Tebé C; Santin M;
Microbiol Spectr; 2021 Dec; 9(3):e0097221. PubMed ID: 34756079
[TBL] [Abstract][Full Text] [Related]
10. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
[TBL] [Abstract][Full Text] [Related]
12. CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status.
Lee MR; Chang CH; Chang LY; Chuang YC; Sun HY; Wang JT; Wang JY
J Infect; 2019 Apr; 78(4):299-304. PubMed ID: 30707912
[TBL] [Abstract][Full Text] [Related]
13. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
Barcellini L; Borroni E; Brown J; Brunetti E; Campisi D; Castellotti PF; Codecasa LR; Cugnata F; Di Serio C; Ferrarese M; Goletti D; Lipman M; Rancoita PM; Russo G; Tadolini M; Vanino E; Cirillo DM
Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CD8
Viana Machado F; Morais C; Santos S; Reis R
Respir Med; 2021; 185():106508. PubMed ID: 34171790
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis.
Sauzullo I; Mengoni F; Mascia C; Pavone P; Savelloni G; Massetti AP; Lichtner M; Vullo V; Mastroianni CM
Med Microbiol Immunol; 2019 Apr; 208(2):171-183. PubMed ID: 30623240
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children.
Buonsenso D; Delogu G; Perricone C; Grossi R; Careddu A; De Maio F; Palucci I; Sanguinetti M; Valentini P; Sali M
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229602
[TBL] [Abstract][Full Text] [Related]
17. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
[TBL] [Abstract][Full Text] [Related]
18. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.
Igari H; Akutsu N; Ishikawa S; Aoyama H; Otsuki K; Hasegawa M; Maruyama M; Tsuyuzaki M; Suzuki K; Saigo K
J Infect Chemother; 2019 Jul; 25(7):537-542. PubMed ID: 30905632
[TBL] [Abstract][Full Text] [Related]
19. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
[TBL] [Abstract][Full Text] [Related]
20. Modulation of interferon-gamma response to QuantiFERON-TB-plus detected by enzyme-linked immunosorbent assay in patients with active and latent tuberculosis infection.
Petruccioli E; Vanini V; Chiacchio T; Cirillo DM; Palmieri F; Ippolito G; Goletti D
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S143-S144. PubMed ID: 28043514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
